| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.009 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |